Head of Investor Relations
Cecilia Ketels
cecilia.ketels@elekta.com
Q1 Earnings Call for investors and analysts at 10am CEST on August 25
Dial-in details
UK: +44 207 107 0613
USA: +1 631 570 5613
Sweden: +46 8 5051 0031
Upcoming
events
Payment date for proposed dividend
Record date for proposed dividend
Q2 report
Payment date for proposed dividend
Record date for proposed dividend
Annual General Meeting 2022
Q1 report
Silent period prior to Q1 report
Annual Report 2021/22
Q4 roadshow, London
Q4 roadshow, Stockholm
Q4 and year-end report
ESTRO investor meeting, Copenhangen
Silent period prior to Q4 report
Jefferies Pan-European Mid-Cap Conference (virtual)
Oppenheim healthcare conference
Carnegie Nordic healthcare conference
Q3 roadshow, London
Q3 roadshow, US (digital)
Q3 roadshow, Stockholm
Q3 report
Silent period prior to Q3 report
JP Morgan healthcare conference (digital)
SEB Nordic seminar (digital)
Berenberg Conference (digital)
Danske Bank winter conference (digital)
Q2 road show, London (digital)
Q2 roadshow, Stockholm
Q2 report
Silent period prior to Q2 report
Q4 results
The strong demand for radiotherapy solutions continued in the fourth quarter and installation volumes came in higher than last year driving revenue growth and sequential margin improvements.
Gustaf Salford, President and CEO
2022-05-25Year-end report, May - April 2021/22
Key figures (rolling 12m)
Capital Markets Day
Our last capital markets day was held digitally on June 7, 2021.
Subscribe to press releases
